Related Experiment Video
Updated: Jul 30, 2026
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
[Paratesticular leiomyosarcoma. Review and update]
Roberto Llarena Ibarguren1, Víctor Azurmendi Sastre, Jesús Martín Bazaco
1Servicio de Urología, Hospital de Cruces, Baracaldo, Vizcaya, España. rllarena@hcru.osakidetza.net
Archivos Espanoles De Urologia
|September 24, 2004
Summary
Paratesticular leiomyosarcoma, a rare cancer, is best treated with radical surgery via an inguinal approach. This approach, involving excision of the spermatic cord and testicle, offers the best chance for successful management of this tumor.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Paratesticular leiomyosarcoma is an exceptionally rare malignancy.
- Management strategies for paratesticular sarcomas require careful consideration due to their specific characteristics.
Observation:
- A case of paratesticular leiomyosarcoma in a 73-year-old male presented as a 4 cm mass.
- The tumor was histologically confirmed as grade 3 leiomyosarcoma with positive desmin and smooth muscle actin staining.
Findings:
- Radical surgery through an inguinal approach, including excision of the spermatic cord and testicle, is the primary treatment.
- The tumor demonstrated resistance to adjuvant oncological treatments.
- No tumor relapse was observed post-surgery in this case.
Implications:
- Radical surgery is the cornerstone of treatment for paratesticular sarcomas, excluding rhabdomyosarcoma, due to radio and chemoresistance.
- The inguinal approach is essential for complete tumor removal.
- Long-term surveillance is critical for detecting potential late relapses, with surgery remaining the main intervention.
- Radiotherapy may be considered for local recurrences post-surgery.
- Survival rates are approximately 75% at 5 years and 50% at 10 years.
